welcome to oneFAPvoice- a positively charged Familial Adenomatous Polyposis community.
- join today!
ACG Clinical Guideline: Genetic Testing and Management of Hereditary Gastrointestinal Cancer Syndromes
source: The American Journal of Gastroenterology
authors: Syngal S, Brand R E, Church J M, Giardiello F M, Hampel H L, Burt R Wsummary/abstract:
This guideline presents recommendations for the management of patients with hereditary gastrointestinal cancer syndromes. The initial assessment is the collection of a family history of cancers and premalignant gastrointestinal conditions and should provide enough information to develop a preliminary determination of the risk of a familial predisposition to cancer. Age at diagnosis and lineage (maternal and/or paternal) should be documented for all diagnoses, especially in first- and second-degree relatives. When indicated, genetic testing for a germline mutation should be done on the most informative candidate(s) identified through the family history evaluation and/or tumor analysis to confirm a diagnosis and allow for predictive testing of at-risk relatives. Genetic testing should be conducted in the context of pre- and post-test genetic counseling to ensure the patient’s informed decision making. Patients who meet clinical criteria for a syndrome as well as those with identified pathogenic germline mutations should receive appropriate surveillance measures in order to minimize their overall risk of developing syndrome-specific cancers. This guideline specifically discusses genetic testing and management of Lynch syndrome, familial adenomatous polyposis (FAP), attenuated familial adenomatous polyposis (AFAP), MUTYH-associated polyposis (MAP), Peutz-Jeghers syndrome, juvenile polyposis syndrome, Cowden syndrome, serrated (hyperplastic) polyposis syndrome, hereditary pancreatic cancer, and hereditary gastric cancer.organization: Harvard Medical School, University of Pittsburgh Medical Center, Cleveland Clinic, Johns Hopkins University School of Medicine, Ohio State University, University of Utah School of Medicine
read more full text source
expertly curated content related to this topic
Diagnosis, Surveillance, and Treatment Strategies For Familial Adenomatous Polyposis: Rationale and UpdateFamilial adenomatous polyposis is charac...
Inactivation of Promoter 1b of APC Causes Partial Gene Silencing: Evidence for a Significant Role of the Promoter in...Familial adenomatous polyposis (FAP) is ...
Guide to Endoscopy of the Ileo-anal Pouch Following Restorative Proctocolectomy with Ileal Pouch-Anal Anastomosis; I...Restorative proctocolectomy (RPC) with i...
Color Genomics Advances Precision Medicine with New Test for Hereditary CancersMarking its one year anniversary since l...
Gender-Specific Aspects of Lynch Syndrome and Familial Adenomatous PolyposisBACKGROUND: The most frequent hereditar...
ADL Launches Revolutionary Urine-Based Diagnostic Test To Detect Precursor To Deadly Colorectal CancerAtlantic Diagnostic Laboratories (ADL), ...
18F-FES PET/CT in Imaging Patients With Desmoid TumorsThis pilot clinical trial studies fluori...